Socrates Papapoulos

8PUBLICATIONS
12CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Rheumatology and arthritisCardiology (incl. cardiovascular diseases)Predictive and prognostic markersOrthopaedics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 30, 2025
Bisphosphonates in the Management of Patients with Postmenopausal Osteoporosis; Back to the Future.

Socrates E Papapoulos, Polyzois Makras

|Mar 17, 2025
Long-term clinical and bone mineral density changes of adult patients with sclerostin deficiency due to van Buchem disease: a follow-up study.

Natasha M Appelman-Dijkstra, Telli Merve Avci, Manuela Schoeb

|Aug 29, 2024
Cyclical Etidronate Reduces the Progression of Arterial Calcifications in Patients with Pseudoxanthoma Elasticum: A 6-Year Prospective Observational Study.

Iris M Harmsen, Tim van den Beukel, Madeleine Kok

|Oct 02, 2023
The relationship between length of denosumab treatment for postmenopausal osteoporosis and serum TRAcP5b measured six months after the last injection.

Polyzois Makras, Maria P Yavropoulou, Stergios A Polyzos

|Mar 16, 2021
Incidence of Hip and Subtrochanteric/Femoral Shaft Fractures in Postmenopausal Women With Osteoporosis in the Phase 3 Long-Term Odanacatib Fracture Trial.

Socrates Papapoulos, Henry Bone, Felicia Cosman

|Aug 22, 2019
Zoledronate for the Prevention of Bone Loss in Women Discontinuing Denosumab Treatment. A Prospective 2-Year Clinical Trial.

Athanasios D Anastasilakis, Socrates E Papapoulos, Stergios A Polyzos

Pageof 2

Frequent Collaborators

4 joint publications

Polyzois Makras

3 joint publications

Athanasios D Anastasilakis

2 joint publications

Stergios A Polyzos

2 joint publications

Maria P Yavropoulou